SCHEMBL9112773

SCHEMBL9112773

[CH]1c2cccc3c2N1CCC3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.42
CES1 P23141 2/20 0.42
ALOX12 P18054 1/20 0.41
HTR2B P41595 1/20 0.38
TSHR P16473 1/20 0.36
SIGMAR1 Q99720 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR1A P08908 1/20 0.34
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
NOTUM Q6P988 1/20 0.33
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60540 0.72 HTR2C (0.69) HTR2CCES1ALOX12HTR2BTSHR
Bromide SCHEMBL8863742 0.70 HTR2C (0.67) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL2084830 0.69 HTR2C (0.47) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL4492996 0.68 HTR2C (0.68) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL2338214 0.68 HTR2C (0.65) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL3333311 0.68 HTR2C (0.46) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL181813 0.68 HTR2C (0.50) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL19122704 0.67 CES1 (0.53) HTR2CCES1ALOX12HTR2BSIGMAR1
SCHEMBL25483519 0.66 CES1 (0.44) HTR2CCES1ALOX12HTR2BTSHR
SCHEMBL20348492 0.65 ALOX12 (0.42) HTR2CCES1ALOX12HTR2BHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5459142-A Autoimmune disease, atherosclerosis, antiischemic agents and nephritis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-10-17 US disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed
EP-0511879-B1 Pyrazine derivatives OTSUKA PHARMA CO LTD (JP) 1995-03-22 EP disclosed
EP-0511879-A1 Pyrazine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-04 EP disclosed